Freeline Therapeutics Holdings plc Quarterly Common Stock, Par or Stated Value Per Share in GBP/shares from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: GBP/shares
Description
Face amount or stated value per share of common stock.
Summary
Freeline Therapeutics Holdings plc quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2018 to Q3 2023.
  • Freeline Therapeutics Holdings plc Common Stock, Par or Stated Value Per Share for the quarter ending September 30, 2023 was 0 GBP/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (GBP/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 0 0 0% Sep 30, 2023 6-K 2023-12-01
Q2 2023 0 0 0% Jun 30, 2023 6-K 2023-08-15
Q1 2023 0 0 0% Mar 31, 2023 6-K 2023-05-30
Q4 2022 0 0 0% Dec 31, 2022 6-K 2023-12-01
Q3 2022 0 0 0% Sep 30, 2022 6-K 2023-12-01
Q2 2022 0 0 0% Jun 30, 2022 6-K 2023-08-15
Q1 2022 0 0 0% Mar 31, 2022 6-K 2023-05-30
Q4 2021 0 0 0% Dec 31, 2021 20-F 2023-04-04
Q3 2021 0 0 0% Sep 30, 2021 6-K 2021-11-09
Q2 2021 0 0 0% Jun 30, 2021 6-K 2021-08-16
Q1 2021 0 0 0% Mar 31, 2021 6-K 2021-05-17
Q4 2020 0 0 Dec 31, 2020 20-F 2023-04-04
Q3 2020 0 Sep 30, 2020 6-K 2021-11-09
Q2 2020 0 0 Jun 30, 2020 6-K 2021-08-16
Q1 2020 0 Mar 31, 2020 6-K 2021-05-17
Q4 2019 0 0 Dec 31, 2019 6-K 2020-10-29
Q2 2019 0 Jun 30, 2019 6-K 2020-10-29
Q4 2018 0 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.